Good Afternoon Group,

I wanted to alert you to this article of interest.

Medical Journals Weigh Plan for Full Drug-Trial Disclosure

June 15, 2004
 By BARRY MEIER

Journals may require drug makers to register trials at their
start in order for results, whether successful or not, to
be published.

http://www.nytimes.com/2004/06/15/business/15drug.html?ex=1088323086&ei=1&en=7654f563e7779b33

Thanks

scott

Scott Davis, CRA
Sponsored Programs Administrator
Office of Research Administration
University of Oklahoma Health Sciences Center
Ph: 405.271.2090   Fax: 405.271.8651
E-mail: xxxxxx@ouhsc.edu

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================